Código QR (código de barras bidimensional)

Randomized Trial of Patiromer on Efficacy to Reduce Episodic Hyperkalemia in Patients with ESKD Treated With Hemodialysis

Introduction: Individuals with end-stage kidney disease (ESKD) maintained on hemodialysis (HD) carry a high risk of cardiac arrhythmias. This risk is heightened by episodic hyperkalemia. The purpose of the study was to investigate whether patiromer administered daily reduced episodes of hyperkalemia...

Fuld beskrivelse

Na minha lista:
Principais autores: John P. Middleton, Shifeng Sun, Susan Murray, Clemontina A. Davenport, James P. Daubert
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2024-11-01
Serier:Kidney International Reports
Fag:
cardiac arrhythmia
cardiovascular risk
clinical trial
hemodialysis
hyperkalemia
Online adgang:http://www.sciencedirect.com/science/article/pii/S2468024924018771
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker